Latest news
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTNVO Q2 Earnings Call Centers on Wegovy Pill and Outlook Lift - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 15:14:00 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - ReutersReuters · Wed, 05 Aug 2026 15:33:40 GMTNovo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5% - CNBCCNBC · Wed, 05 Aug 2026 06:11:31 GMTNovo Nordisk Earnings Beat But Study Data, Wegovy Pill Sales Underwhelm -- Market Talk - MoomooMoomoo · Wed, 05 Aug 2026 05:53:00 GMTNovo outlook hike falls flat as Wegovy pill sales fail to impress - ReutersReuters · Tue, 04 Aug 2026 21:15:59 GMTNovo Nordisk Stock Slides After Outlook Disappoints. But Wegovy Sales Continue to Climb - International Business TimesInternational Business Times · Tue, 04 Aug 2026 19:02:35 GMTOzempic Maker Novo Nordisk Raises Outlook but Sales Fall on Tough Comparison, Stock Tanks - inklinkl · Tue, 04 Aug 2026 18:38:07 GMT